Impact of DPP-4 inhibitors on plasma levels of BNP and NT-pro-BNP in type 2 diabetes mellitus

Mu, LY; Wang, Z; Ren, JM; Xiong, XW; Jin, ZN; Liu, X

Jin, ZN (通讯作者)，Capital Med Univ, Beijing Tiantan Hosp, Dept Cardiol, Beijing, Peoples R China.;Liu, X (通讯作者)，Capital Med Univ, Beijing Tiantan Hosp, Dept Pharm, Beijing, Peoples R China.;Jin, ZN (通讯作者)，Capital Med Univ, Beijing Tiantan Hosp, Dept Cardiol & Macrovasc Dis, Beijing, Peoples R China.

DIABETOLOGY & METABOLIC SYNDROME, 2022; 14 (1):

Abstract

Background Dipeptidyl peptidase-4 inhibitors (DPP-4i) decrease glucose levels by regulating incretin peptides in type 2 diabetes mellitus (T2DM). This......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索